ValiRx Share News (VAL)

ValiRx Loss Narrows As Progress Is Made On Cancer Compounds

ValiRx Says ValiSeek Begins Manufacturing VAL401 For Clinical Trial

ValiRx Says ValiSeek Gets US Patent For VAL401 In Adenocarcinoma

ValiRx Shares Fall After Bracknor Converts GBP200,000 Of Loan Notes (ALLISS)

ValiRx Receives Conversion Notice For GBP90,000 From Bracknor (ALLISS)

ValiRx Strikes GBP4 Million Convertible Funding Deal With Bracknor (ALLISS)

ValiRx Hires Consultancy Firm Burns McClellan To Boost US Profile

ValiRx Raises Funds To Back Ongoing Drug Trials (ALLISS)

ValiRx achieves success in latest VAL201 trial

(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,

ValiRx Says Final Dose Escalation For VAL201 Trials Approved

ValiRx confident in two ongoing clinical trials

(ShareCast News) - ValiRx was confident in the potential of two of its compounds on Tuesday, in its quarterly update on its ongoing clinical trials. The AIM-traded life science firm, with a focus on cancer diagnostics and therapeutics for personalised medicine, said that recent testing had shown VAL

WINNERS & LOSERS SUMMARY: Bond Disclosure Sends Legal & General Higher

ValiRx Shares Rise After Positive Clinical Trial News For VAL201

ValiRx Says VAL201 Dose Escalation Complete, Preparing VAL401 Trials

ValiRx Opens US Office In Boston, Massachusetts